CellScreen Applied Research Center, Semmelweis University Medical School, Budapest, Hungary.
Br J Pharmacol. 2009 Nov;158(6):1565-78. doi: 10.1111/j.1476-5381.2009.00432.x.
We have established an in vitro model of acute tubular necrosis in rat kidney tubular cells, using combined oxygen-glucose deprivation (COGD) and screened a library of 1280 pharmacologically active compounds for cytoprotective effects.
We used in vitro cell-based, high throughput, screening, with cells subjected to COGD using hypoxia chambers, followed by re-oxygenation. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and the Alamar Blue assay measured mitochondrial respiration and the lactate dehydrogenase assay was used to indicate cell death. ATP levels were measured using a luminometric assay.
Adenosine markedly reduced cellular injury, with maximal cytoprotective effect at 100 microM and an EC(50) value of 14 microM. Inosine was also found to be cytoprotective. The selective A(3) adenosine receptor antagonist MRS 1523 attenuated the protective effects of adenosine and inosine, while an A(3) adenosine receptor agonist provided a partial protective effect. Adenosine deaminase inhibition attenuated the cytoprotective effect of adenosine but not of inosine during COGD. Inhibition of adenosine kinase reduced the protective effects of both adenosine and inosine during COGD. Pretreatment of the cells with adenosine or inosine markedly protected against the fall in cellular ATP content in the cells subjected to COGD.
The cytoprotection elicited by adenosine and inosine in a model of renal ischaemia involved both interactions with cell surface adenosine receptors on renal tubular epithelial cells and intracellular metabolism and conversion of adenosine to ATP.
我们已经建立了一种大鼠肾小管细胞急性肾小管坏死的体外模型,使用联合氧葡萄糖剥夺(COGD),并筛选了 1280 种药理学活性化合物文库,以寻找具有细胞保护作用的化合物。
我们使用体外基于细胞的高通量筛选方法,用缺氧室使细胞经历 COGD,然后再进行复氧。3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)和 Alamar Blue 测定法测量线粒体呼吸,乳酸脱氢酶测定法用于指示细胞死亡。使用发光测定法测量 ATP 水平。
腺苷显著减轻细胞损伤,最大细胞保护作用在 100 μM 时达到,EC(50)值为 14 μM。肌苷也具有细胞保护作用。选择性 A(3)腺苷受体拮抗剂 MRS 1523 减弱了腺苷和肌苷的保护作用,而 A(3)腺苷受体激动剂提供了部分保护作用。在 COGD 期间,腺苷脱氨酶抑制减弱了腺苷的细胞保护作用,但不影响肌苷。腺苷激酶抑制降低了 COGD 期间腺苷和肌苷的保护作用。细胞预处理用腺苷或肌苷可显著保护 COGD 后细胞内 ATP 含量下降。
在肾缺血模型中,腺苷和肌苷引起的细胞保护作用既涉及肾小管上皮细胞表面的细胞表面腺苷受体相互作用,也涉及细胞内代谢和将腺苷转化为 ATP。